Gov. Andrew M. Cuomo announced that the artist Anthony Goicolea had been selected to design the monument in Hudson River Park in Manhattan.
NYS Entity Status
NYS Filing Date
MAY 08, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC LIMITED LIABILITY COMPANY
2014 - FLYING POINT DESIGN AND DEVELOPMENT, LLC
AROUND THE WEB
- A Winning Design for a New York Monument to Gay and Transgender People
By JOSHUA BARONE - Sunday Jun 25, 2017
- Dan Loeb buys a chunk of Nestle, blasts ‘staid’ culture
By Carleton English - Monday Jun 26, 2017
Dan Loeb just placed his biggest bet ever on a chocolate company. The activist investor’s hedge fund Third Point LLC amassed a $3.5 billion stake in Nestle, the world’s largest packaged foods company, representing roughly 1.25 percent of the Swiss-based company’s shares. Loeb is hoping to reinvigorate the brand amid changing food tastes as well...
- Fit City: Taking Night-Life Cue, Gyms Lower the Lights
By TATIANA BONCOMPAGNI - Tuesday Jun 13, 2017
Cycling, boxing and running studios, as well as some full-service gyms, are using sophisticated lighting systems to heighten the exercise experience.
- Pride 2017: New York’s L.G.B.T.Q. Story Began Well Before Stonewall
By LIAM STACK - Monday Jun 19, 2017
The gay bar’s 1969 patron-police battle, hailed as a starting point, actually followed many events in the city, now mapped in a sites project.
- Future of City Transport: Flying Taxis
Wednesday Jun 21, 2017
Flying car concepts and designs have been around for awhile. But some firms are looking to transform the idea and provide a point-to-point passenger vehicle service–or a flying taxi. Here are three companies pushing to revolutionize city transport. Graphic Simulation: Volocopter
- “It’s Shame On Us If We Blow It”: Highlights From NY Seizes the Momentum
By Ben Fidler - Wednesday Jun 7, 2017
Mike Foley, a drug industry veteran and director of the Tri-Institutional Therapeutics Discovery Institute, has a pointed message for the New York life sciences industry: Don’t waste the moment. Changing the course of New York biotech has been a saga that dates back to the 1990s, and as Xconomy has detailed, progress has been made […]